Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Opinion in Obstetrics & Gynecology|January 16, 2007
HER2/neu role in breast cancer: from a prognostic foe to a predictive friendGianluigi Ferretti, Alessandra Felici, Paola Papaldo, et al.
Cancer Epidemiology|October 16, 2010
Colorectal cancer after breast cancer: a case-control studyLupe Sanchez-Mete, Irene Venturo, Paola Papaldo, et al.
Drugs of Today (Barcelona, Spain : 1998)|May 6, 2003
Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumorsSerena Di Cosimo, Gianluigi Ferretti, Paola Papaldo, et al.
Breast (Edinburgh, Scotland)|September 1, 2005
Is anthracycline-based chemotherapy alone adequate for young women with estrogen receptor-positive breast cancer?Paola Papaldo, Serena Di Cosimo, Gianluigi Ferretti, et al.
Cancer Investigation|November 30, 2004
Effect of filgrastim on serum lactate dehydrogenase and alkaline phosphatase values in early breast cancer patientsPaola Papaldo, Serena Di Cosimo, Gianluigi Ferretti, et al.
Thrombosis Research|June 20, 2006
Major bleedings in the comparisons between low-molecular weight heparin versus oral anticoagulant therapy for venous thromboembolismGianluigi Ferretti, Emilio Bria, Diana Giannarelli, et al.
Acta Oncologica (Stockholm, Sweden)|December 24, 2003
Docetaxel in advanced gastric cancer--review of the main clinical trialsSerena Di Cosimo, Gianluigi Ferretti, Nicola Fazio, et al.
Anticancer Research|August 17, 2005
Nail disorders in a woman treated with ixabepilone for metastatic breast cancerAndrea Alimonti, Chiara Nardoni, Paola Papaldo, et al.
BMC Cancer|October 23, 2012
Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapyAlessandra Fabi, Michelangelo Russillo, Gianluigi Ferretti, et al.
Breast (Edinburgh, Scotland)|May 3, 2008
Do HER-2 positive metastatic breast cancer patients benefit from the use of trastuzumab beyond disease progression? A mono-institutional experience and systematic review of observational studiesAlessandra Fabi, Giulio Metro, Gianluigi Ferretti, et al.
Pageof 4